Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 54 Records) |
Query Trace: Thrombosis and CYP2C9[original query] |
---|
Effects on bleeding complications of pharmacogenetic testing for initial dosing of vitamin K antagonists: a systematic review and meta-analysis. Journal of thrombosis and haemostasis : JTH 2014 Sep 12 (9): 1480-7. Franchini M, Mengoli C, Cruciani M, Bonfanti C, Mannucci P |
VKORC1 and CYP2C9 genotypes in Egyptian patients with warfarin resistance. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2014 Jun . Azzam Hanan, Elwakeel Hossam, Awad Ibrahim, El-Farahaty Reham, El-Gilany Abdel-Hady, El-Sharawy Sola |
High resolution melting method to detect single nucleotide polymorphism of VKORC1 and CYP2C9. International journal of clinical and experimental pathology 2014 7 (5): 2558-64. Chen Chunxia, Li Siyue, Lu Xiaojun, Tan Bin, Huang Chunyan, Qin |
Influence of CYP2C9 polymorphism and phenytoin co-administration on acenocoumarol dose in patients with cerebral venous thrombosis. Thrombosis research 2014 May 133 (5): 729-35. De Tanima, Christopher Rita, Nagaraja Dindag |
Polymorphisms of CYP2C9, VKORC1, MDR1, APOE and UGT1A1 genes and the therapeutic warfarin dose in Brazilian patients with thrombosis: a prospective cohort study. Molecular diagnosis & therapy 2014 Dec 18 (6): 675-83. de Oliveira Almeida Vanessa Cristina, Ribeiro Daniel Dias, Gomes Karina Braga, Godard Ana Lúcia Brunial |
Pharmacogenomic Testing and Warfarin Management. Oncology nursing forum 2015 Sep 42 (5): 563-5. Maluso Andr |
The Influence of VKORC1 Polymorphisms on Warfarin Doses in Thai Patients with Deep Vein Thrombosis. Journal of the Medical Association of Thailand = Chotmaihet thangphaet 2015 Jun 98 (6): 549-54. Sermsathanasawadi Nuttawut, Sritongsathian Chukij, Pongrattanaman Nunthapol, Praditsuktavorn Banjerd, Hongku Kiattisak, Wongwanit Chumpol, Ruangsetakit Chanean, Chinsakchai Khamin, Mutirangura Pramook, Poungvarin Narav |
Influence of CYP2C9 polymorphism on the fall in International Normalized Ratio in patients interrupting warfarin therapy before elective surgery. Journal of thrombosis and haemostasis : JTH 2015 Aug 13 (8): 1436-40. Abohelaika S, Wynne H, Avery P, Kamali |
Effects of genetic factors to stent thrombosis due to clopidogrel resistance after coronary stent placement. Cellular and molecular biology (Noisy-le-Grand, France) 2016 62 (1): 51-5. Kirac D, Erdem A, Avcilar T, Yesilcimen K, Guney A I, Emre A, Yazici S, Terzi S, Kaspar E C, Cetin S E, Isbir |
[FREQUENCY OF POLYMORPHISM OF VKORC1 AND CYP2C9 GENES IN TWO REGIONS OF GEORGIA]. Georgian medical news 2016 Jan (250): 46-51. Jokhadze T, Kakauridze N, Buadze T, Gaiozishvili M, Lezhava |
VKORC1 and CYP2C9 polymorphisms related to adverse events in case-control cohort of anticoagulated patients. Medicine 2016 Dec 95 (52): e5451. Misasi Silvia, Martini Giuliana, Paoletti Oriana, Calza Stefano, Scovoli Giovanni, Marengoni Alessandra, Testa Sophie, Caimi Luigi, Marchina Eleono |
Identification of novel variants associated with warfarin stable dosage by use of a two-stage extreme phenotype strategy. Journal of thrombosis and haemostasis : JTH 2016 Oct . Luo Zhiying, Li Xi, Zhu Mingfeng, Tang Jie, Li Zhi, Zhou Xinming, Song Guobao, Liu Zhaoqian, Zhou Honghao, Zhang W |
High prevalence of VKORC1*3 (G9041A) genetic polymorphism in north Indians: A study on patients with cardiac disorders on acenocoumarol. Drug discoveries & therapeutics 2016 9 (6): 404-10. Sehgal Tushar, Hira Jasbir Kaur, Ahluwalia Jasmina, Das Reena, Vijayvergiya Rajesh, Rana Sandip Singh, Varma Neel |
Association Between the Lower Extremity Deep Venous Thrombosis, the Warfarin Maintenance Dose, and CYP2C9*3, CYP2D6*10, and CYP3A5*3 Genetic Polymorphisms: A Case-Control Study. Genetic testing and molecular biomarkers 2017 Sep . Ju Shang, Gao Yu, Cao Xin, Zhang Xiao-Fu, Yan Cheng-Cheng, Liu Feng-To |
Genotyping of CYP2C9 and VKORC1 polymorphisms predicts south Indian patients with deep vein thrombosis as fast metabolizers of warfarin/acenocoumarin. Drug discoveries & therapeutics 2017 9 11 (4): 198-205. Arunkumar Ganesan, Vishnuprabu Durairajpandian, Nupur Bitt, Vidyasagaran Thiruvengadam, Murugan Avaniyapuram Kannan, Munirajan Arasambattu Kann |
Long-term outcomes of elderly patients with CYP2C9 and VKORC1 variants treated with vitamin K antagonists. Journal of thrombosis and haemostasis : JTH 2017 Aug . Nagler M, Angelillo-Scherrer A, Méan M, Limacher A, Abbal C, Righini M, Beer J H, Osterwalder J, Frauchiger B, Aschwanden M, Matter C M, Kucher N, Cornuz J, Banyai M, Husmann M, Staub D, Mazzolai L, Hugli O, Rodondi N, Aujesky |
Integrated analysis of genetic variation and gene expression reveals novel variant for increased warfarin dose requirement in African Americans. Journal of thrombosis and haemostasis : JTH 2017 Jan . Hernandez Wenndy, Gamazon Eric R, Aquino-Michaels Keston, Smithberger Erin, O'Brien Travis J, Harralson Arthur F, Tuck Matthew, Barbour April, Cavallari Larisa H, Perera Minoli |
The Influence of CYP2C9 and VKORC1 Gene Polymorphisms on the Response to Warfarin in Egyptians. Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion 2018 Apr 34 (2): 328-336. Bedewy Ahmed M L, Sheweita Salah A, Mostafa Mostafa Hasan, Kandil Lamia Sae |
Ensemble of machine learning algorithms using the stacked generalization approach to estimate the warfarin dose. PloS one 2018 10 13 (10): e0205872. Ma Zhiyuan, Wang Ping, Gao Zehui, Wang Ruobing, Khalighi Korou |
Effects of genetic variants on platelet reactivity and one-year clinical outcomes after percutaneous coronary intervention: A prospective multicentre registry study. Scientific reports 2018 1 8 (1): 1229. Joo Hyung Joon, Ahn Sung Gyun, Park Jae Hyoung, Park Ji Young, Hong Soon Jun, Kim Seok-Yeon, Choi WoongGil, Gwon HyeonCheol, Lim Young-Hyo, Kim Weon, Kang Woong Chol, Cho Yun-Hyeong, Kim Yong Hoon, Yoon JungHan, Shin WonYong, Hong Myeong-Ki, Garg Scot, Jang Yangsoo, Lim Do-S |
Impact of genetic and clinical factors on warfarin therapy in patients early after heart valve replacement surgery. European journal of clinical pharmacology 2019 8 75 (12): 1685-1693. Li Boxia, Liu Ruisheng, Wang Chengqi, Ren Changan, Zhang Shiming, Zhang Fan, Zhang Jianping, Liu Shidong, Wei Yuhui, Liu Wenjing, Song Bing, Wu Xin |
Warfarin dose requirement in patients having severe thrombosis or thrombophilia. British journal of clinical pharmacology 2019 Apr . Helin Tuukka A, Joutsi-Korhonen Lotta, Asmundela Heidi, Niemi Mikko, Orpana Arto, Lassila Riit |
Prosthetic valve thrombosis - association of genetic polymorphisms of VKORC1, CYP2C9 and CYP4F2 genes. Medicine 2019 Feb 98 (6): e14365. Sr Kalpana, G Bharath, Jain Simran, Moorthy Nagaraja, Manjunath Satvic C, Christopher Ri |
Profiling of warfarin pharmacokinetics-associated genetic variants: Black Africans portray unique genetic markers important for an African specific warfarin pharmacogenetics-dosing algorithm. Journal of thrombosis and haemostasis : JTH 2021 Aug . Ndadza Arinao, Muyambo Sarudzai, Mntla Pindile, Wonkam Ambroise, Chimusa Emile, Kengne Andre P, Ntsekhe Mpiko, Dandara Coll |
Genetic Polymorphism Effect on Warfarin-Rifampin Interaction: A Case Report and Review of Literature. Pharmacogenomics and personalized medicine 2021 2 14 149-156. Salem Muhammad, Eljilany Islam, El-Bardissy Ahmed, Elewa Haz |
Hyper-responsiveness to warfarin in a young patient with the VKORC1 -1639GA/CYP2C9*1*46 genotype: a case report. Thrombosis journal 2022 10 20 (1): 65. Aldiban Weam, Altawil Yara, Hussein Samir, Aljamali Majd, Youssef Lama |
COX-1, COX-2 and CYP2C19 variations may be related to cardiovascular events due to acetylsalicylic acid resistance. Molecular biology reports 2022 1 49 (4): 3007-3014. Kirac Deniz, Yaman Aysun Erdem, Doran Tansu, Mihmanli Mujgan, Keles Elif Cigd |
FREQUENCY OF VKORC1 AND CYP2C9 GENES POLYMORPHISM IN ABKHAZIAN POPULATION. Georgian medical news 2023 7 (338): 96-101. T Lezhava, N Kakauridze, T Jokhadze, T Buadze, M Gaiozishvili, Kh Gargulia, T Sig |
CYP2C9 Polymorphisms and the Risk of Cardiovascular Events in Patients Treated with Clopidogrel: Combined Data from the POPular Genetics and POPular AGE Trials. American journal of cardiovascular drugs : drugs, devices, and other interventions 2023 2 23 (2): 165-172. van den Broek Wout W A, Mani Nabil, Azzahhafi Jaouad, Ten Berg Jurriën |
Acute kidney injury interacts with VKORC1 genotype on initiative warfarin dose among heart surgery recipients: a real-world research. Scientific reports 2023 12 13 (1): 21750. Liang Xiong, Feng Yu, Weihong Ge, Hang |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: